France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026

Sep.08.2025
France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026
France's Decree No. 2025-898 bans all oral nicotine products nationwide six months after publication. Medicines and medical devices are exempt. This includes nicotine pouches, gum, lozenges, and other forms, regardless of origin. The decree is based on the Public Health Code and applies to mainland France and Wallis and Futuna Islands.

Key Points:

 

·Ban Scope: The production, manufacture, transport, import, export, possession, offer/sale, purchase, and use of these products are prohibited within France.

·Formats include: nicotine pouches (including porous pouches), pastes, beads, liquids, chewing gum, lozenges, films/strips, etc. (regardless of whether the nicotine is natural or synthetic).

·Exemptions:
1. Chewing tobacco;
2. Legally approved pharmaceuticals, medical devices, and their medicinal raw materials;
3. Food (naturally containing trace amounts of nicotine or meeting EU pesticide residue limits).

·Research Exceptions: Case-by-case exemptions for research purposes may be issued by the Minister of Health, subject to separate conditions and procedures.

·Effective Date: Le Monde and Radio France Internationale reported that the ban will officially take effect in March 2026.

 


 

2Firsts, September 8, 2025 - According to the French government's official website on September 5, the French government published Decree No. 2025-898 in the Official Gazette, which will take effect six months from its publication. This ban applies nationwide to the production, sale, possession, purchase, and use of "nicotine-containing products for oral use," with the exception of medicines and medical devices.

 

The decree specifies that the ban covers all stages of the process: production, manufacturing, transportation, import/export, possession, provision/transfer, purchase, and actual use.

 

Formats subject to the ban include:

 

Nicotine pouches (including porous pouches), pastes, beads, liquids, chewing gum, lozenges, films/strips, and more (regardless of whether the nicotine is natural or synthetic).

 

Exemptions include:

 

·Chewing tobacco;

·Legally approved medicines, medical devices, and their medicinal raw materials;

·Food (naturally containing nicotine or meeting EU pesticide residue limits).

 

The decree provides for scientific research exceptions, which can be granted for specific research projects upon the signature of the Minister of Health and in compliance with specified conditions.

 

The background document states that nicotine is classified as a "toxic substance" under the French Public Health Code, allowing for a ban on "any related operation" by decree of the Council of State. The decree has also been submitted to the European Union for technical regulatory information (notification number 2025/0110/FR) as required.

 

The decree indicates that, in addition to mainland France, the relevant provisions also apply to the Wallis and Futuna Islands.

 

Le Monde and Radio France Internationale reported that the ban will officially take effect in March 2026.

 

Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
The show had become an important check-in point for Chinese manufacturers and brand owners looking for signs of change in the U.S. market after months of softer demand. Instead, participants said the event highlighted a more restrained mood: traffic in the vape section was uneven, standout launches were limited, and conversations often failed to turn into orders.
Special Report
Apr.12
Can hookah go institutional? A hookah company seeking to go public makes its case with capital, technology and regulation
Can hookah go institutional? A hookah company seeking to go public makes its case with capital, technology and regulation
2Firsts explored whether hookah can evolve into a more mature and governable category by interviewing Dubai-based hookah company AIR. AIR argues that strong margins, OOKA’s closed-system model and the prospect of differentiated regulation could support that shift. The larger question is whether this is simply AIR’s capital-markets narrative, or an early sign that competition, regulation and category boundaries in hookah are beginning to change.
Apr.02
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
The Philippine Department of Health said it is pushing for a total ban on vape products. If a full ban is not feasible, DOH officer-in-charge Director Dr. Dominic Maddumba said vape products should at least be limited to plain tobacco flavors to reduce their appeal to minors.
May.06 by 2FIRSTS.ai
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts held a UK vape duty stamp compliance exchange in Shenzhen on May 14, bringing together representatives from nearly 20 companies. The session addressed Vaping Products Duty, duty stamp applications, UK agency qualifications and warehousing, while introducing 2Firsts Compliance Solutions’ UK service.
Events
May.17
Latvian Parliament Gives Initial Support to E-Cigarette Deposit Scheme Amendments
Latvian Parliament Gives Initial Support to E-Cigarette Deposit Scheme Amendments
On April 1, Latvia’s parliament gave conceptual support to amendments to the Waste Management Law that would introduce a deposit system for e-cigarettes in order to reduce pollution and environmental harm caused by these products.
Apr.03 by 2FIRSTS.ai
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Researchers at the Chinese Academy of Sciences reconstructed nicotine biosynthesis in non-tobacco plants and yeast systems, highlighting how advances in synthetic biology could gradually reshape future nicotine production technologies and challenge regulatory frameworks built around tobacco-derived definitions.
Special Report
May.07